[{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Bone marrow transplant","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Maintenance","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_setting":"Conditioning","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Morphologic leukemia-free state","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial response","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Salvage","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Minor response","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Maintenance","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment":"Partial remission","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Immunotherapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Complete remission","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Radiation therapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":7,"response_to_treatment":"Complete response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Stem cell transplant","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial remission","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","days_per_cycle":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Hormonal therapy","Photodynamic therapy"],"treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune stable disease (iSD)","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Preventative","number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","No treatment","Other targeting molecular therapy"],"treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":7,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Major response","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","days_per_cycle":3,"response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery"],"treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_setting":"Preventative","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune confirmed progressive disease (iCPD)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":1,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_setting":"Conditioning","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Minor response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_setting":"Maintenance","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":1,"response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Adjuvant","treatment_intent":"Screening","response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Mobilization","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Other targeting molecular therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Induction","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Preventative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial response","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery"],"treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Conditioning","treatment_intent":"Palliative","days_per_cycle":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Salvage","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Radiation therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune partial response (iPR)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Conditioning","treatment_intent":"Diagnostic","days_per_cycle":2,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Morphologic leukemia-free state","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed stable disease","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Maintenance","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Complete remission","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_setting":"Radiosensitization","days_per_cycle":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Stable disease","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Chemotherapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment":"Complete remission","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Progressive disease","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":7,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":86,"day_interval":2580},"days_per_cycle":1,"number_of_cycles":4,"response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed stable disease","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Immunotherapy"],"treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Advanced/Metastatic","number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Adjuvant","treatment_intent":"Screening","response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":90,"day_interval":2700},"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant","No treatment"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Maintenance","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery","Radiation therapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":6,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Hormonal therapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Adjuvant","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy"],"treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":5,"line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_intent":"Curative","days_per_cycle":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Conditioning","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Major response","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Advanced/Metastatic","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"No evidence of disease (NED)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":96,"day_interval":2880},"days_per_cycle":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_intent":"Palliative","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Conditioning","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Conditioning","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Neoadjuvant","treatment_intent":"Curative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Stable disease","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":7,"line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Immunotherapy","No treatment"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Preventative","number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Surgery","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Mobilization","treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Radiation therapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Salvage","treatment_intent":"Guidance","number_of_cycles":3,"line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":7,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment","Hormonal therapy"],"treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Locally advanced","days_per_cycle":5,"response_to_treatment_criteria_method":"Blazer score","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Hormonal therapy"],"treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":75,"day_interval":2250},"days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":4,"line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_setting":"Conditioning","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant","Surgery"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Maintenance","treatment_intent":"Forensic","number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Minor response","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Preventative","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Mobilization","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Conditioning","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Maintenance","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment":"Complete remission","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Stem cell transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Radiosensitization","days_per_cycle":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_setting":"Conditioning","treatment_intent":"Guidance","number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Immunotherapy"],"treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment":"Immune partial response (iPR)","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":7,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Conditioning","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":7,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Conditioning","treatment_intent":"Screening","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Stem cell transplant","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Primary refractory disease","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment":"Immune partial response (iPR)","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_setting":"Locally advanced","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune complete response (iCR)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Preventative","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Conditioning","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Bone marrow transplant","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Induction","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","response_to_treatment":"Partial response","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Maintenance","days_per_cycle":7,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Conditioning","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Progressive disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Conditioning","days_per_cycle":6,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Salvage","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Bone marrow transplant","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Locally advanced","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Preventative","treatment_intent":"Screening","number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Partial response","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Locally advanced","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Salvage","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","number_of_cycles":3,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Photodynamic therapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Induction","treatment_intent":"Screening","response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Stem cell transplant","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Photodynamic therapy"],"treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_setting":"Preventative","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment":"Minor response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_intent":"Curative","days_per_cycle":7,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Primary refractory disease","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Radiation therapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Maintenance","treatment_intent":"Palliative","number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune stable disease (iSD)","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Stable disease","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Neoadjuvant","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Immunotherapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Induction","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":6,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Advanced/Metastatic","number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Major response","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_intent":"Diagnostic","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Maintenance","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Radiosensitization","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Salvage","treatment_intent":"Guidance","days_per_cycle":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Maintenance","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Hormonal therapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Adjuvant","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Chemotherapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_intent":"Palliative","number_of_cycles":3,"response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Neoadjuvant","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"Immune complete response (iCR)","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment":"Complete response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_setting":"Conditioning","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Primary refractory disease","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Bone marrow transplant","Surgery"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Salvage","treatment_intent":"Guidance","days_per_cycle":7,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed partial response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Preventative","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment":"Physician assessed partial response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Conditioning","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Hormonal therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Induction","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","days_per_cycle":5,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":4,"response_to_treatment":"Minor response","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant"],"treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Induction","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Induction","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_intent":"Forensic","number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Other targeting molecular therapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Preventive","days_per_cycle":1,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Major response","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Immunotherapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Stem cell transplant","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune complete response (iCR)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","No treatment"],"treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Induction","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":2,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Locally advanced","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Progressive disease","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Major response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Conditioning","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed stable disease","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","No treatment"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Induction","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_setting":"Radiosensitization","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Hormonal therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Conditioning","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment":"Physician assessed complete response","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","No treatment","Hormonal therapy"],"treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Neoadjuvant","number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Locally advanced","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Progressive disease","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Locally advanced","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Immunotherapy","Surgery"],"is_primary_treatment":"No","treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Preventive","days_per_cycle":6,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Advanced/Metastatic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Induction","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Stable disease","line_of_treatment":4,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Induction","treatment_intent":"Guidance","days_per_cycle":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Maintenance","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment":"Partial remission","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Chemotherapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_setting":"Conditioning","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial response","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Neoadjuvant","treatment_intent":"Curative","number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_setting":"Neoadjuvant","treatment_intent":"Curative","number_of_cycles":3,"response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed partial response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Neoadjuvant","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Chemotherapy"],"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_setting":"Maintenance","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":6,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Radiosensitization","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Adjuvant","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_intent":"Preventive","days_per_cycle":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_intent":"Screening","number_of_cycles":3,"response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Radiation therapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":1,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Induction","treatment_intent":"Supportive","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Salvage","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Maintenance","treatment_intent":"Preventive","number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Progressive disease","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Radiation therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Advanced/Metastatic","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Neoadjuvant","response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_setting":"Conditioning","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Adjuvant","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment":"Progressive disease","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Immunotherapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Salvage","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Major response","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_setting":"Conditioning","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Induction","treatment_intent":"Curative","number_of_cycles":3,"response_to_treatment":"Complete response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Bone marrow transplant","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Primary refractory disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_intent":"Diagnostic","response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial remission","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_intent":"Guidance","days_per_cycle":6,"response_to_treatment":"Stable disease","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Induction","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":50,"day_interval":1500},"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Progressive disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Preventative","days_per_cycle":7,"number_of_cycles":4,"line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Major response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":1,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Chemotherapy"],"is_primary_treatment":"Yes","treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Maintenance","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Maintenance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial remission","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","No treatment","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Locally advanced","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment":"Physician assessed stable disease","line_of_treatment":4,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Partial response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Stable disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Immunotherapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Stable disease","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Immunotherapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Major response","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Adjuvant","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Preventative","treatment_intent":"Forensic","number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy","Surgery"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":3,"response_to_treatment_criteria_method":"AML Response Criteria","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":7,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Progressive disease","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Induction","days_per_cycle":2,"response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_setting":"Mobilization","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":1,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_setting":"Preventative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed complete response","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","No treatment","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_intent":"Forensic","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":6,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete response","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Immunotherapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Neoadjuvant","treatment_intent":"Curative","days_per_cycle":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment":"Immune complete response (iCR)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_setting":"Mobilization","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed partial response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Conditioning","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Immunotherapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Conditioning","treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":89,"day_interval":2670},"days_per_cycle":2,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment":"Immune complete response (iCR)","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Induction","treatment_intent":"Preventive","number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune stable disease (iSD)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":69,"day_interval":2070},"days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","No treatment","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Radiation therapy"],"treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Adjuvant","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed stable disease","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Adjuvant","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Adjuvant","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Stem cell transplant","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Induction","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":4,"line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Preventative","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Photodynamic therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Preventative","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Major response","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Minor response"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Radiosensitization","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Radiosensitization","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","days_per_cycle":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Induction","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Mobilization","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Induction","days_per_cycle":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Stable disease","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Conditioning","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_setting":"Preventative","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Preventative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Stem cell transplant","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":50,"day_interval":1500},"days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Induction","treatment_intent":"Palliative","days_per_cycle":2,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Primary refractory disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":6,"response_to_treatment":"Partial remission","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_intent":"Curative","response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Conditioning","treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Hormonal therapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_setting":"Salvage","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment":"Minor response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_intent":"Supportive","number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Radiation therapy","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Salvage","treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed partial response","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Morphologic leukemia-free state","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial remission","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed complete response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Induction","treatment_intent":"Forensic","number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Salvage","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Progressive disease","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Hormonal therapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Salvage","treatment_intent":"Palliative","number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Locally advanced","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_setting":"Locally advanced","treatment_intent":"Supportive","response_to_treatment":"Progressive disease","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Mobilization","treatment_intent":"Screening","days_per_cycle":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Stable disease","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_setting":"Neoadjuvant","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Locally advanced","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":97,"day_interval":2910},"days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Conditioning","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Salvage","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","No treatment","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":1,"response_to_treatment":"Complete response","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Induction","days_per_cycle":6,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed stable disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Induction","treatment_intent":"Preventive","number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Induction","treatment_intent":"Forensic","number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Conditioning","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Chemotherapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Mobilization","treatment_intent":"Screening","days_per_cycle":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Mobilization","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Photodynamic therapy","Stem cell transplant"],"treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Locally advanced","treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial response","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial response","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_setting":"Mobilization","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Immunotherapy"],"treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":7,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Mobilization","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Immunotherapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Adjuvant","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Chemotherapy","Surgery"],"treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":7,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Induction","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Maintenance","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Primary refractory disease","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Progressive disease","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Chemotherapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":5,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment":"Partial remission","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":2,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_setting":"Adjuvant","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_intent":"Diagnostic","days_per_cycle":1,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Adjuvant","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Primary refractory disease","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Adjuvant","treatment_intent":"Curative","days_per_cycle":1,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Major response","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Stem cell transplant","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune partial response (iPR)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Locally advanced","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Maintenance","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_intent":"Curative","response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Radiosensitization","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_setting":"Preventative","treatment_intent":"Preventive","number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Hormonal therapy"],"treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"Primary refractory disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery","Hormonal therapy"],"treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_setting":"Salvage","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_setting":"Mobilization","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment":"Complete remission","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Maintenance","treatment_intent":"Screening","number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Stem cell transplant","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Primary refractory disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_setting":"Adjuvant","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial response","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_intent":"Guidance","days_per_cycle":1,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_setting":"Preventative","treatment_intent":"Palliative","number_of_cycles":5,"response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Morphologic leukemia-free state"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Induction","treatment_intent":"Palliative","response_to_treatment":"Complete response"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Salvage","treatment_intent":"Screening","number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune stable disease (iSD)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_setting":"Mobilization","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment":"Immune complete response (iCR)","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Minor response","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Preventative","treatment_intent":"Guidance","response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Conditioning","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Radiation therapy"],"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment":"Partial remission","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Radiation therapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Other targeting molecular therapy","Hormonal therapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Adjuvant","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Stable disease","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Radiosensitization","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Locally advanced","treatment_intent":"Preventive","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":3,"response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":7,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Bone marrow transplant"],"treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Radiosensitization","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":61,"day_interval":1830},"days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Immune partial response (iPR)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Adjuvant","days_per_cycle":2,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":1,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":7,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Maintenance","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":4,"line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Preventative","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":4,"line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_setting":"Conditioning","number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Stem cell transplant","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":4,"line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Locally advanced","treatment_intent":"Curative","number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Maintenance","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Radiosensitization","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Conditioning","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Adjuvant","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant","Surgery"],"treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":4,"line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Mobilization","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Induction","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Maintenance","days_per_cycle":1,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Advanced/Metastatic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial remission","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Stem cell transplant","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Guidance","number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed complete response","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Primary refractory disease","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Mobilization","treatment_intent":"Preventive","number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Conditioning","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Immunotherapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":79,"day_interval":2370},"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":2,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Stem cell transplant","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Maintenance","treatment_intent":"Palliative","response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Locally advanced","treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Major response","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Maintenance","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Locally advanced","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Locally advanced","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Immunotherapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Chemotherapy","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Morphologic leukemia-free state","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Mobilization","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_intent":"Supportive","days_per_cycle":7,"response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Radiation therapy","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Other targeting molecular therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Radiation therapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Preventative","treatment_intent":"Palliative","number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","response_to_treatment_criteria_method":"iRECIST","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete response","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","No treatment","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Neoadjuvant","days_per_cycle":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Induction","treatment_intent":"Screening","number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Primary refractory disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment","Surgery"],"treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune complete response (iCR)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Immunotherapy"],"treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment":"Primary refractory disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":2,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed stable disease","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_setting":"Radiosensitization","number_of_cycles":4,"line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Radiation therapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Conditioning","treatment_intent":"Forensic","number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed partial response","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Mobilization","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":7,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy"],"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Salvage","days_per_cycle":6,"number_of_cycles":3,"line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Bone marrow transplant","Radiation therapy"],"treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Locally advanced","treatment_intent":"Preventive","number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed partial response","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":62,"day_interval":1860},"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_intent":"Preventive","days_per_cycle":1,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Maintenance","treatment_intent":"Screening","number_of_cycles":3,"line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Adjuvant","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Locally advanced","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Mobilization","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed complete response","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Maintenance","treatment_intent":"Guidance","days_per_cycle":1,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed complete response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment":"Partial response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed partial response"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Salvage","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":3,"line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Radiation therapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Conditioning","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_intent":"Preventive","days_per_cycle":1,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":7,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Photodynamic therapy","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment":"Progressive disease","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Stem cell transplant","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":5,"line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Locally advanced","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment":"Physician assessed stable disease","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Other targeting molecular therapy","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":78,"day_interval":2340},"days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Preventative","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Chemotherapy","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Immunotherapy"],"treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Morphologic leukemia-free state","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Stem cell transplant","Hormonal therapy"],"treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Adjuvant","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Stable disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment":"Primary refractory disease","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_setting":"Induction","treatment_intent":"Curative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_intent":"Forensic","number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Radiosensitization","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Bone marrow transplant","Radiation therapy"],"treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment":"Physician assessed partial response","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Chemotherapy","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Preventative","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Photodynamic therapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Surgery","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Locally advanced","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Stable disease","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune stable disease (iSD)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Other targeting molecular therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","No treatment","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":50,"day_interval":1500},"days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Mobilization","treatment_intent":"Curative","response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_setting":"Radiosensitization","days_per_cycle":1,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune complete response (iCR)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Salvage","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":2,"response_to_treatment":"Physician assessed partial response","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial remission","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Physician assessed partial response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial response","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment":"Partial response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Induction","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Major response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":95,"day_interval":2850},"days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Salvage","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":4,"line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy"],"treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial response","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Advanced/Metastatic","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Induction","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_intent":"Guidance","response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_setting":"Mobilization","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Salvage","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Minor response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment"],"treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","No treatment","Bone marrow transplant"],"treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial response","line_of_treatment":4,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_setting":"Maintenance","treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed complete response","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Stable disease","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_intent":"Palliative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Induction","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Photodynamic therapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_intent":"Supportive","number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Locally advanced","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Conditioning","treatment_intent":"Supportive","response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Stem cell transplant","Surgery"],"treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed complete response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Photodynamic therapy"],"treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Induction","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Conditioning","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Surgery","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Primary refractory disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Maintenance","days_per_cycle":2,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Chemotherapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Locally advanced","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Primary refractory disease","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Other targeting molecular therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":92,"day_interval":2760},"days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial response","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":1,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune stable disease (iSD)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Locally advanced","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Neoadjuvant","number_of_cycles":4,"response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Chemotherapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Maintenance","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Stable disease","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Induction","treatment_intent":"Supportive","number_of_cycles":4,"response_to_treatment":"Stable disease","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_intent":"Preventive","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":66,"day_interval":1980},"days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Molecular relapse (after CR MRD-)","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Primary refractory disease","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Preventative","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Maintenance","treatment_intent":"Forensic","number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Partial response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Stem cell transplant","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Conditioning","treatment_intent":"Preventive","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","No treatment","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Conditioning","treatment_intent":"Forensic","days_per_cycle":7,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":77,"day_interval":2310},"days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Surgery","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Progressive disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Adjuvant","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed partial response","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_setting":"Preventative","treatment_intent":"Screening","days_per_cycle":5,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Photodynamic therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Locally advanced","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":3,"line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Preventative","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":2,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Chemotherapy","No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","No treatment","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment":"Physician assessed stable disease","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"No","treatment_setting":"Induction","treatment_intent":"Palliative","number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Adjuvant","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy","Bone marrow transplant"],"treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Mobilization","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Salvage","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Immune complete response (iCR)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Maintenance","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Maintenance","treatment_intent":"Curative","number_of_cycles":4,"line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Salvage","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_setting":"Conditioning","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Surgery","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Maintenance","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Major response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_intent":"Palliative","days_per_cycle":2,"response_to_treatment":"Physician assessed complete response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Major response","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial remission","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Mobilization","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Partial response","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Partial response","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Minor response","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Chemotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Preventative","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_setting":"Conditioning","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment":"No evidence of disease (NED)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","No treatment","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":1,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Radiation therapy","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_setting":"Induction","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery","Stem cell transplant"],"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Conditioning","number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Locally advanced","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment":"Complete remission","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Physician assessed partial response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_intent":"Palliative","days_per_cycle":1,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Stem cell transplant","No treatment"],"treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete response","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Mobilization","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Photodynamic therapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_setting":"Maintenance","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":83,"day_interval":2490},"treatment_setting":"Advanced/Metastatic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment":"Minor response","line_of_treatment":3,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Maintenance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Stem cell transplant","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":70,"day_interval":2100},"treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":77,"day_interval":2310},"treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":6,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Salvage","number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery","No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial remission","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Chemotherapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Minor response","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Surgery","Radiation therapy"],"treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment":"Major response","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":10,"day_interval":300},"treatment_setting":"Adjuvant","treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_setting":"Neoadjuvant","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Primary refractory disease","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Radiation therapy","Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_intent":"Preventive","days_per_cycle":7,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Conditioning","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment":"Primary refractory disease","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Surgery","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","No treatment"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Mobilization","treatment_intent":"Preventive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment":"Progressive disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Radiation therapy","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_intent":"Forensic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":4,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_setting":"Preventative","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Major response","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","No treatment","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Induction","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment":"Physician assessed stable disease","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed complete response","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":76,"day_interval":2280},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Partial response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment":"Complete response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Neoadjuvant","number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":50,"day_interval":1500},"treatment_setting":"Salvage","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Progressive disease","line_of_treatment":1,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Radiation therapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed partial response","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Salvage","treatment_intent":"Guidance","number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Conditioning","number_of_cycles":3,"response_to_treatment":"Minor response","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Maintenance","treatment_intent":"Guidance","number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_intent":"Palliative","days_per_cycle":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Induction","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Adjuvant","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Photodynamic therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":2,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Stem cell transplant","Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":60,"day_interval":1800},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":75,"day_interval":2250},"treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Locally advanced","treatment_intent":"Screening","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Major response","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Bone marrow transplant","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Preventative","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Primary refractory disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Maintenance","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":6,"response_to_treatment_criteria_method":"AML Response Criteria","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":20,"day_interval":600},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_end_date":{"month_interval":98,"day_interval":2940},"treatment_setting":"Salvage","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Chemotherapy"],"is_primary_treatment":"Yes","treatment_setting":"Conditioning","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Chemotherapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_setting":"Adjuvant","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment":"Partial response","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Preventative","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_intent":"Preventive","number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Adjuvant","treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Conditioning","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Bone marrow transplant","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":58,"day_interval":1740},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":3,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_setting":"Neoadjuvant","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Primary refractory disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Maintenance","treatment_intent":"Screening","days_per_cycle":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Radiosensitization","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":30,"day_interval":900},"treatment_setting":"Maintenance","treatment_intent":"Palliative","number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Conditioning","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Radiation therapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment":"Immune complete response (iCR)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Salvage","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Curative","number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial remission","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Other targeting molecular therapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_intent":"Palliative","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment":"Partial response","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Radiosensitization","treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Neoadjuvant","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_setting":"Induction","treatment_intent":"Supportive","number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Radiosensitization","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Primary refractory disease","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Mobilization","treatment_intent":"Guidance","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Hormonal therapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment":"Stable disease","status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","No treatment"],"treatment_start_date":{"month_interval":33,"day_interval":990},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":71,"day_interval":2130},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":81,"day_interval":2430},"treatment_setting":"Induction","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Minor response","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Maintenance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Advanced/Metastatic","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Stem cell transplant","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Induction","treatment_intent":"Curative","number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Minor response"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":3,"line_of_treatment":4,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","number_of_cycles":3,"line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed complete response","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":47,"day_interval":1410},"treatment_end_date":{"month_interval":78,"day_interval":2340},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"treatment_start_date":{"month_interval":14,"day_interval":420},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","line_of_treatment":2,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":11,"day_interval":330},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Induction","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Induction","treatment_intent":"Supportive","number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":66,"day_interval":1980},"treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Chemotherapy","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":6,"day_interval":180},"treatment_setting":"Induction","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":2,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Immunotherapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":2,"day_interval":60},"treatment_setting":"Radiosensitization","treatment_intent":"Guidance","days_per_cycle":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Preventative","number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":4,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Primary refractory disease","line_of_treatment":5,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":39,"day_interval":1170},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Salvage","treatment_intent":"Preventive","days_per_cycle":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Partial remission","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Chemotherapy"],"treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Locally advanced","treatment_intent":"Supportive","number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Stable disease","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":28,"day_interval":840},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Mobilization","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete remission","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Bone marrow transplant"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Maintenance","number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed complete response","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Other targeting molecular therapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":100,"day_interval":3000},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Physician assessed stable disease","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Physician assessed complete response","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Adjuvant","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":5,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy","Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":91,"day_interval":2730},"days_per_cycle":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":1,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":51,"day_interval":1530},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":2,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_setting":"Neoadjuvant","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","No treatment","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Locally advanced","treatment_intent":"Forensic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Mobilization","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":1},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"treatment_start_date":{"month_interval":45,"day_interval":1350},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Maintenance","treatment_intent":"Palliative","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_setting":"Adjuvant","treatment_intent":"Diagnostic","days_per_cycle":1,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission","line_of_treatment":3,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Physician assessed complete response","line_of_treatment":3,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":59,"day_interval":1770},"days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":93,"day_interval":2790},"treatment_setting":"Conditioning","treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_setting":"Preventative","treatment_intent":"Palliative","days_per_cycle":6,"response_to_treatment_criteria_method":"AML Response Criteria","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":89,"day_interval":2670},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_setting":"Induction","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","Surgery"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":55,"day_interval":1650},"treatment_setting":"Neoadjuvant","treatment_intent":"Preventive","response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_setting":"Mobilization","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Morphologic leukemia-free state","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":3,"day_interval":90},"treatment_end_date":{"month_interval":60,"day_interval":1800},"days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Physician assessed complete response","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_setting":"Preventative","treatment_intent":"Supportive","days_per_cycle":6,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":92,"day_interval":2760},"treatment_setting":"Neoadjuvant","treatment_intent":"Curative","days_per_cycle":5,"number_of_cycles":3,"response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Conditioning","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":48,"day_interval":1440},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune complete response (iCR)","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":31,"day_interval":930},"treatment_end_date":{"month_interval":73,"day_interval":2190},"treatment_setting":"Induction","treatment_intent":"Preventive","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Complete response","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Neoadjuvant","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":4,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Bone marrow transplant"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":40,"day_interval":1200},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Chemotherapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":72,"day_interval":2160},"treatment_setting":"Locally advanced","treatment_intent":"Palliative","days_per_cycle":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":5,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_intent":"Guidance","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery"],"is_primary_treatment":"Unknown","treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":2,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":16,"day_interval":480},"treatment_end_date":{"month_interval":82,"day_interval":2460},"days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Stable disease","status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Salvage","treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":37,"day_interval":1110},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Radiosensitization","days_per_cycle":3,"line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":79,"day_interval":2370},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":27,"day_interval":810},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Conditioning","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Complete response","status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"treatment_start_date":{"month_interval":44,"day_interval":1320},"treatment_end_date":{"month_interval":74,"day_interval":2220},"treatment_setting":"Conditioning","treatment_intent":"Palliative","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":86,"day_interval":2580},"treatment_setting":"Advanced/Metastatic","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment"],"treatment_start_date":{"month_interval":4,"day_interval":120},"treatment_setting":"Mobilization","treatment_intent":"Diagnostic","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment":"Morphologic leukemia-free state"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":62,"day_interval":1860},"treatment_setting":"Locally advanced","treatment_intent":"Preventive","days_per_cycle":1,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":3},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":46,"day_interval":1380},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery","Immunotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":85,"day_interval":2550},"treatment_setting":"Neoadjuvant","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":50,"day_interval":1500},"treatment_end_date":{"month_interval":94,"day_interval":2820},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":2,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_intent":"Palliative","days_per_cycle":6,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":5,"day_interval":150},"treatment_setting":"Preventative","treatment_intent":"Guidance","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Morphologic leukemia-free state","line_of_treatment":2,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Immunotherapy","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":34,"day_interval":1020},"treatment_end_date":{"month_interval":90,"day_interval":2700},"treatment_intent":"Screening","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":2,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":13,"day_interval":390},"treatment_end_date":{"month_interval":91,"day_interval":2730},"treatment_setting":"Conditioning","treatment_intent":"Palliative","number_of_cycles":5,"response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Hormonal therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":26,"day_interval":780},"treatment_end_date":{"month_interval":96,"day_interval":2880},"treatment_setting":"Salvage","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Complete response","line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Mobilization","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","line_of_treatment":4,"status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"treatment_end_date":{"month_interval":67,"day_interval":2010},"treatment_setting":"Mobilization","treatment_intent":"Curative","number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"No evidence of disease (NED)","status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":36,"day_interval":1080},"treatment_end_date":{"month_interval":64,"day_interval":1920},"treatment_intent":"Supportive","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment":"No evidence of disease (NED)","line_of_treatment":3,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_start_date":{"month_interval":24,"day_interval":720},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Maintenance","treatment_intent":"Guidance","number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Physician assessed stable disease","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":12,"day_interval":360},"treatment_end_date":{"month_interval":61,"day_interval":1830},"treatment_setting":"Induction","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response","line_of_treatment":1,"status_of_treatment":"Other"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_setting":"Maintenance","treatment_intent":"Palliative","number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Preventative","number_of_cycles":5,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Major response","line_of_treatment":3,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":22,"day_interval":660},"treatment_end_date":{"month_interval":96,"day_interval":2880},"days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Partial remission","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"No","treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Conditioning","treatment_intent":"Supportive","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","status_of_treatment":"Unknown"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":7,"day_interval":210},"treatment_end_date":{"month_interval":80,"day_interval":2400},"treatment_setting":"Salvage","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"No evidence of disease (NED)","line_of_treatment":4},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":65,"day_interval":1950},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":2,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Other targeting molecular therapy","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":43,"day_interval":1290},"treatment_end_date":{"month_interval":95,"day_interval":2850},"treatment_setting":"Mobilization","treatment_intent":"Forensic","number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Molecular relapse (after CR MRD-)","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"treatment_start_date":{"month_interval":38,"day_interval":1140},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":25,"day_interval":750},"treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":15,"day_interval":450},"treatment_end_date":{"month_interval":84,"day_interval":2520},"treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":23,"day_interval":690},"treatment_end_date":{"month_interval":54,"day_interval":1620},"treatment_intent":"Forensic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Stable disease","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Chemotherapy","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":35,"day_interval":1050},"treatment_end_date":{"month_interval":83,"day_interval":2490},"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":32,"day_interval":960},"treatment_end_date":{"month_interval":82,"day_interval":2460},"treatment_setting":"Conditioning","treatment_intent":"Curative","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Minor response","status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":99,"day_interval":2970},"treatment_setting":"Maintenance","treatment_intent":"Screening","number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Immunotherapy","Other targeting molecular therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":8,"day_interval":240},"treatment_end_date":{"month_interval":56,"day_interval":1680},"treatment_setting":"Adjuvant","treatment_intent":"Palliative","days_per_cycle":2,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Primary refractory disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":18,"day_interval":540},"treatment_end_date":{"month_interval":68,"day_interval":2040},"treatment_setting":"Radiosensitization","treatment_intent":"Forensic","days_per_cycle":2,"response_to_treatment_criteria_method":"iRECIST","line_of_treatment":4,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","Stem cell transplant"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":29,"day_interval":870},"treatment_setting":"Mobilization","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Physician assessed partial response","line_of_treatment":4,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_end_date":{"month_interval":69,"day_interval":2070},"treatment_setting":"Neoadjuvant","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial response","line_of_treatment":5},
{"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Radiation therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":9,"day_interval":270},"treatment_setting":"Adjuvant","treatment_intent":"Guidance","days_per_cycle":4,"number_of_cycles":5,"line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Bone marrow transplant"],"treatment_start_date":{"month_interval":19,"day_interval":570},"treatment_end_date":{"month_interval":53,"day_interval":1590},"treatment_setting":"Locally advanced","treatment_intent":"Curative","number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Immune stable disease (iSD)","line_of_treatment":3,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Photodynamic therapy"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":1,"day_interval":30},"treatment_end_date":{"month_interval":88,"day_interval":2640},"treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Stable disease","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":49,"day_interval":1470},"treatment_end_date":{"month_interval":97,"day_interval":2910},"treatment_setting":"Adjuvant","treatment_intent":"Supportive","days_per_cycle":5,"number_of_cycles":4,"response_to_treatment":"Physician assessed stable disease"},
{"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":{"month_interval":21,"day_interval":630},"treatment_end_date":{"month_interval":59,"day_interval":1770},"treatment_setting":"Locally advanced","treatment_intent":"Curative","line_of_treatment":2},
{"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","Photodynamic therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":17,"day_interval":510},"treatment_end_date":{"month_interval":63,"day_interval":1890},"treatment_setting":"Conditioning","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune uncomfirmed progressive disease (iUPD)","line_of_treatment":1,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":{"month_interval":42,"day_interval":1260},"treatment_end_date":{"month_interval":52,"day_interval":1560},"treatment_setting":"Advanced/Metastatic","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy","Bone marrow transplant","Radiation therapy"],"is_primary_treatment":"No","treatment_end_date":{"month_interval":57,"day_interval":1710},"treatment_setting":"Locally advanced","number_of_cycles":3,"response_to_treatment_criteria_method":"RECIST 1.1","line_of_treatment":1,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Bone marrow transplant","Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":{"month_interval":41,"day_interval":1230},"treatment_end_date":{"month_interval":87,"day_interval":2610},"treatment_intent":"Screening","days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":5,"status_of_treatment":"Treatment incomplete because patient died"}]